Skip to main content
. 2014 May 29;9(5):e97954. doi: 10.1371/journal.pone.0097954

Table 2. Overview of clinical datasets employed in this study.

Clinical Variables Cohort A (20) Cohort B (20) Combined Cohort (40)
Pathological Gleason Score 3+3 4 (20%) 1 (5%) 5 (12.5%)
3+4 7 (35%) 17 (85%) 24 (60%)
4+3 7 (35%) 2 (10%) 9 (22.5%)
3+5 1 (5%) - (-) 1 (2.5%)
4+4 1 (5%) - (-) 1 (2.5%)
Pathologic Stage pT2 8 (40%) 12 (60%) 20 (50%)
pT3a 9 (45%) 6 (30%) 15 (37.5%)
pT3b 3 (15%) 2 (10%) 5 (12.5%)